Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
Details for Australian Patent Application No. 2006304305 (hide)
International Classifications
Event Publications
3 April 2008 PCT application entered the National Phase
PCT publication WO2007/047496 Priority application(s): WO2007/047496
28 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
1 April 2010 Application Accepted
Published as AU-B-2006304305
29 July 2010 Standard Patent Sealed
11 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006304318-Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
2006304304-Lighter device with flow restrictor and methods of manufacturing and testing same
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser